Development and characterization of manganese-doped hydroxyapatite-incorporated wet-electrospun polycaprolactone scaffolds

Bioceramic-incorporated polymer-based scaffolds have gained more interest as a promising and effective approach in bone tissue engineering (BTE) applications. This study is the first to investigate the role of incorporated manganese-doped hydroxyapatite (Mn-HA) and gelatin coating in increased bioactivity and biological properties, specifically the cell attachment potencies of three-dimensional (3D) porous electrospun polycaprolactone (PCL). In this context, novel 3D porous composite scaffolds were synthesized by wet electrospinning of PCL incorporated with Mn-HA. The scaffolds were then coated with a thin gelatin layer to enhance the cell adhesion capacity. The effects of Mn-HA and the gelatin coating were evaluated in terms of structural, physicochemical, and biological properties. The results demonstrated that Mn-HA was successfully synthesized with doping of 2 mol% Mn, with MnSO<sub>4</sub>(manganese sulfate) and MnCl<sub>2</sub>(manganese chloride) precursors. Mn-HA powder with a MnSO<sub>4</sub>precursor indicated better cell viability results. Therefore, Mn-HA/PCL scaffolds with 2.5% and 5% (w/w) bioceramic content were prepared with the MnSO<sub>4</sub>precursor. The scaffolds' porosity increased from 24% (PCL/gelatin group) to approximately 34% in both the 2.5% and 5% (w/w) bioceramic-containing groups. The addition of Mn-HA powder improved the<i>in vitro</i>bioactivity and degradation rate of the scaffolds. Specifically, the 5% and 2.5% (w/w) Mn-HA incorporated scaffolds indicated 40% and 30% weight loss after 21 d of incubation, respectively. In contrast to the PCL/gelatin and HA-containing groups, the Mn-doped HA containing scaffolds exhibited a weight loss of around 17%-20%, indicating a decrease in degradation. The presence of the Mn-HA powder and gelatin coating elevated the cell viability results significantly, as opposed to the PCL scaffolds. Incorporation of 5% (w/w) Mn-HA improved the alkaline phosphatase activity and intracellular calcium levels, contrary to other groups. Thus, the incorporation of Mn-doped HA and gelatin into the PCL scaffold supports the potency towards properties required for BTE applications and suggests it as a prospective biomaterial for further evaluations.

Authors

Institutions

Publication Details

Journal
Biomedical Materials
Published
2025-11-05
DOI
https://doi.org/10.1088/1748-605x/ae1c07
Primary Topic
Bone Tissue Engineering Materials
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Development and characterization of manganese-doped hydroxyapatite-incorporated wet-electrospun polycaprolactone scaffolds

Hossein Jodati, Dilek Keskin, Zafer Evis, Alaleh Samiei
Biomedical Materials
Bone Tissue Engineering Materials
article

Development and characterization of manganese-doped hydroxyapatite-incorporated wet-electrospun polycaprolactone scaffolds

Hossein Jodati, Dilek Keskin, Zafer Evis, Alaleh Samiei
article en

Abstract

Bioceramic-incorporated polymer-based scaffolds have gained more interest as a promising and effective approach in bone tissue engineering (BTE) applications. This study is the first to investigate the role of incorporated manganese-doped hydroxyapatite (Mn-HA) and gelatin coating in increased bioactivity and biological properties, specifically the cell attachment potencies of three-dimensional (3D) porous electrospun polycaprolactone (PCL). In this context, novel 3D porous composite scaffolds were synthesized by wet electrospinning of PCL incorporated with Mn-HA. The scaffolds were then coated with a thin gelatin layer to enhance the cell adhesion capacity. The effects of Mn-HA and the gelatin coating were evaluated in terms of structural, physicochemical, and biological properties. The results demonstrated that Mn-HA was successfully synthesized with doping of 2 mol% Mn, with MnSO<sub>4</sub>(manganese sulfate) and MnCl<sub>2</sub>(manganese chloride) precursors. Mn-HA powder with a MnSO<sub>4</sub>precursor indicated better cell viability results. Therefore, Mn-HA/PCL scaffolds with 2.5% and 5% (w/w) bioceramic content were prepared with the MnSO<sub>4</sub>precursor. The scaffolds' porosity increased from 24% (PCL/gelatin group) to approximately 34% in both the 2.5% and 5% (w/w) bioceramic-containing groups. The addition of Mn-HA powder improved the<i>in vitro</i>bioactivity and degradation rate of the scaffolds. Specifically, the 5% and 2.5% (w/w) Mn-HA incorporated scaffolds indicated 40% and 30% weight loss after 21 d of incubation, respectively. In contrast to the PCL/gelatin and HA-containing groups, the Mn-doped HA containing scaffolds exhibited a weight loss of around 17%-20%, indicating a decrease in degradation. The presence of the Mn-HA powder and gelatin coating elevated the cell viability results significantly, as opposed to the PCL scaffolds. Incorporation of 5% (w/w) Mn-HA improved the alkaline phosphatase activity and intracellular calcium levels, contrary to other groups. Thus, the incorporation of Mn-doped HA and gelatin into the PCL scaffold supports the potency towards properties required for BTE applications and suggests it as a prospective biomaterial for further evaluations.

Biomedical MaterialsVol. 21(1)
Middle East Technical University (TR)
Openalex Percentile: Top 68%
Bone Tissue Engineering Materials
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.